These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6878206)
1. MRFIT and clinical practice. Arnold CB Prev Med; 1983 May; 12(3):475-7. PubMed ID: 6878206 [No Abstract] [Full Text] [Related]
2. MRFIT and the goals of The Journal. Lundberg GD JAMA; 1982 Sep; 248(12):1501. PubMed ID: 7050443 [No Abstract] [Full Text] [Related]
3. A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). The MRFIT Research Group. Neaton JD; Bartsch GE; Broste SK; Cohen JD; Simon NM Control Clin Trials; 1991 Dec; 12(6):731-40. PubMed ID: 1665114 [No Abstract] [Full Text] [Related]
5. The Multiple Risk Factor Intervention Trial (MRFIT). A return to a landmark trial. Gotto AM JAMA; 1997 Feb; 277(7):595-7. PubMed ID: 9032169 [No Abstract] [Full Text] [Related]
6. Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT. Holme I; Helgeland A; Hjermann I; Leren P; Lund-Larsen PG JAMA; 1984 Mar; 251(10):1298-9. PubMed ID: 6366258 [TBL] [Abstract][Full Text] [Related]
7. Nutrition in the Multiple Risk Factor Intervention Trial (MRFIT). Farrand ME; Mojonnier L J Am Diet Assoc; 1980 Apr; 76(4):347-51. PubMed ID: 7391467 [TBL] [Abstract][Full Text] [Related]
8. The multiple risk factor intervention trial (MRFIT). VII. A comparison of risk factor changes between the two study groups. Neaton JD; Broste S; Cohen L; Fishman EL; Kjelsberg MO; Schoenberger J Prev Med; 1981 Jul; 10(4):519-43. PubMed ID: 7027241 [No Abstract] [Full Text] [Related]
11. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials. Cutler JA; Neaton JD; Hulley SB; Kuller L; Paul O; Stamler J Prev Med; 1985 May; 14(3):293-311. PubMed ID: 3903734 [TBL] [Abstract][Full Text] [Related]
12. Current status of coronary prevention. Lessons from the Framingham study. Dawber TR; Kannel WB Prev Med; 1972 Dec; 1(4):499-512. PubMed ID: 4670405 [No Abstract] [Full Text] [Related]
13. The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. The Hypertension Detection and Follow-up Program Cooperative Research Group. Circulation; 1984 Dec; 70(6):996-1003. PubMed ID: 6388901 [TBL] [Abstract][Full Text] [Related]
14. [Target blood pressure values from the cardiologic viewpoint]. Klein W Wien Med Wochenschr; 1999; 149(23-24):625-8. PubMed ID: 10721157 [TBL] [Abstract][Full Text] [Related]
15. The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipids. Caggiula AW; Christakis G; Farrand M; Hulley SB; Johnson R; Lasser NL; Stamler J; Widdowson G Prev Med; 1981 Jul; 10(4):443-75. PubMed ID: 7027238 [No Abstract] [Full Text] [Related]
19. The multiple risk factor intervention trial (MRFIT). A national study of primary prevention of coronary heart disease. JAMA; 1976 Feb; 235(8):825-7. PubMed ID: 946311 [No Abstract] [Full Text] [Related]
20. Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial. Rautaharju PM; Neaton JD Clin Invest Med; 1987 Nov; 10(6):606-15. PubMed ID: 3326700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]